New CRPS Study Offers Hope for Recovery
The latest research on complex regional pain syndrome offers hope for significant recovery within 18 months of diagnosis.
The latest research on complex regional pain syndrome offers hope for significant recovery within 18 months of diagnosis.
The FDA cleared Convatec's InnovaBurn placental extracellular matrix medical device for managing second-degree burns.
Multi Radiance Medical has become the first laser therapy manufacturer to receive FDA clearance to treat pain associated with fibromyalgia.
Using anti-inflammation drugs and steroids to relieve pain could increase the chances of developing chronic pain, according to researchers.
NeuroMetrix Inc announces the strategic launch of its FDA-cleared Quell Fibromyalgia device through the Pathfinder Program.
The COVID-19 pandemic pushed academia into the 21st century, according to Kirsten Davin, OTD, OTR/L, ATP, SMS.